Literature DB >> 2473970

Pediatric nasopharyngeal carcinoma: long term follow-up of 29 patients.

W J Pao1, H O Hustu, E C Douglass, N S Beckford, L E Kun.   

Abstract

Twenty-nine untreated children diagnosed with nasopharyngeal carcinoma were consecutively admitted to St. Jude Children's Research Hospital from 1962 to 1986. The age of the patients ranged from 6 to 19 years (median of 13) at diagnosis. Histologically, all had lymphoepithelioma. Patients were retrospectively staged in the American Joint Committee System. Disease extent was T1 (n = 5), T2 (n = 7), T3 (n = 9), T4 (n = 8); N0 (n = 1), N2 (n = 7), N3 (n = 21). Two patients had distant metastasis (M1) on admission, both ultimately succumbed to their disease. Twenty-seven patients were seen initially without metastatic disease: one received pre-irradiation vincristine, 17 were treated with concomitant radiotherapy and cyclophosphamide. From 1981 to the present, four patients received pre-irradiation and one received post-irradiation cisplatin-bleomycin, vinblastine (CDDP-BLEO-VLB) regimens. Four patients received radiotherapy alone. All patients completed chemotherapy and radiation therapy. Twenty-five patients had complete tumor clearance and four had a partial response. Overall, 14 patients are alive continuously without relapse with a median follow-up of 11 years (range 4 to 20). All patients who relapsed did so within 2 years postirradiation. Four patients failed locally--all had advanced (T3-T4) local disease at presentation and three of the failures were at the margin of treatment portals. Thirteen patients failed with distant metastasis. The major prognostic factor in these patients was the local extent of disease. Among the 27 M0 patients, all ten patients with T1-2 tumors are disease-free, whereas four of nine patients with T3 and two of eight patients with T4 tumors are alive and well. In the 16 patients who are long term survivors, eight have mild neck atrophy, two have shortening of the clavicles; except for one patient who required a neck brace for shoulder drop, all had normal function. Among the seven pre-pubertal patients who are long term survivors, three have decreased growth, including one with documented decreased growth hormone. Two patients developed irregular menstrual periods. One patient developed hypothyroidism, and another had a thyroid adenoma. One patient developed bleomycin pneumonitis and one patient who received pre- and post-irradiation chemotherapy died of laryngeal edema and fibrosis, in remission. Radiotherapy is the major modality in the therapy of childhood nasopharyngeal carcinoma. The long term toxicity of radiotherapy plus or minus chemotherapy is acceptable. In early stage tumors (T1-2, N1-2), radiotherapy alone (55-60 Gy) appears to be sufficient for disease control.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2473970     DOI: 10.1016/0360-3016(89)90443-4

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  10 in total

1.  Prognostic factors and long-term outcomes of childhood nasopharyngeal carcinoma.

Authors:  Daniel Ka Leung Cheuk; Catherine A Billups; Michael G Martin; Cynthia R Roland; Raul C Ribeiro; Matthew J Krasin; Carlos Rodriguez-Galindo
Journal:  Cancer       Date:  2010-08-24       Impact factor: 6.860

2.  Hepatic late adverse effects after antineoplastic treatment for childhood cancer.

Authors:  Renée L Mulder; Dorine Bresters; Malon Van den Hof; Bart Gp Koot; Sharon M Castellino; Yoon Kong K Loke; Piet N Post; Aleida Postma; László P Szőnyi; Gill A Levitt; Edit Bardi; Roderick Skinner; Elvira C van Dalen
Journal:  Cochrane Database Syst Rev       Date:  2019-04-15

3.  Long-term radiotherapy related complications in children with head and neck cancer: Another era for pediatric oncologic pathology.

Authors:  Nikolaos Eleftheriadis; Christos Papaloukas; Damianos Eleftheriadis; Apostolos Hatzitolios; Ioulia Ioannidou-Marathiotou; Kiki Pistevou-Gompaki
Journal:  Int J Gen Med       Date:  2009-07-30

4.  Long term chemoradiotherapy-related dental and skeletal complications in a young female with nasopharyngeal carcinoma.

Authors:  Ioulia Ioannidou-Marathiotou; Kyriaki Pistevou-Gompaki; Nikolaos Eleftheriadis; Christos Papaloukas
Journal:  Int J Gen Med       Date:  2010-07-21

5.  Nasopharyngeal carcinoma in adolescents: a retrospective review of 42 patients.

Authors:  Said Afqir; Nabil Ismaili; Khaoula Alaoui; Samir Ahid; Jean-Pierre Lotz; Elizabeth Horn; Touria Bouhafa; Redouane Abouqal; Hassan Errihani
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-01-22       Impact factor: 2.503

6.  Gene Therapy for Pediatric Cancer: State of the Art and Future Perspectives.

Authors:  Ettore Biagi; Catherine Bollard; Raphael Rousseau; Malcolm Brenner
Journal:  J Biomed Biotechnol       Date:  2003

7.  Pediatric Nasopharyngeal Cancer: Case Report and Review of the Literature.

Authors:  Alejandro González-Motta; Garvin González; Yurany Bermudéz; Maria C Maldonado; Javier M Castañeda; David Lopéz; Martha Cotes-Mestre
Journal:  Cureus       Date:  2016-02-15

8.  CD4-positive lymphoepithelial-like carcinoma: Report of unusual case.

Authors:  Luaay Aziz; Raya Saab; Toufic Eid; Mousa A Al-Abbadi
Journal:  Avicenna J Med       Date:  2018 Apr-Jun

9.  From Juvenile Nasopharyngeal Angiofibroma to Nasopharyngeal Carcinoma; A Rare Case Report of Nasopharyngeal Mass.

Authors:  Saleh Mohebbi; Mohammad Aghajanpour
Journal:  Bull Emerg Trauma       Date:  2019-10

10.  Clinical Implications of Plasma Epstein-Barr Virus DNA in Children and Adolescent Nasopharyngeal Carcinoma Patients Receiving Intensity-Modulated Radiotherapy.

Authors:  Wenze Qiu; Xing Lv; Xiang Guo; Yawei Yuan
Journal:  Front Oncol       Date:  2020-03-31       Impact factor: 6.244

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.